Free press releases distribution network?

Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



TOPRA Announces 2nd Annual North America Symposium - Carlos Langezaal, Director, Regulatory Development - Neuroscience, Sanofi-Aventis, Bridgewater New Jersey and Head of TOPRA North America, today announced that the 2nd TOPRA North America Symposium on Wed, May 2 at the Westin Grand Hotel, in DC
TOPRA Announces 2nd Annual North America Symposium

 

PRZOOM - /newswire/ - London, United Kingdom, 2007/04/05 - Carlos Langezaal, Director, Regulatory Development - Neuroscience, Sanofi-Aventis, Bridgewater New Jersey and Head of TOPRA North America, today announced that the 2nd TOPRA North America Symposium on Wed, May 2 at the Westin Grand Hotel, in DC.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Conference Agenda Attracts Global Regulatory Leaders

Carlos Langezaal, Director, Regulatory Development - Neuroscience, Sanofi-Aventis, Bridgewater New Jersey and Head of TOPRA North America, today announced that the 2nd TOPRA North America Symposium will be held on Wednesday, May 2 at the Westin Grand Hotel in Washington, DC.

The agenda for the symposium has been divided into two sections to address two critical topics facing regulatory professionals in the industry today. Industry professionals and representatives from regulatory authorities including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMEA) will gather to discuss pediatric regulations and risk management plans.

“TOPRA’s Second Annual North America Symposium has been designed as an information sharing and networking event that provides opportunities for attendees to learn in an interactive setting”, noted Mr. Langezaal. “US Regulatory Affairs professionals are dealing with increasingly complex duties and need to understand how to develop strategies for successful global development programs. This year’s topics are vital to the lifecycle management of a product portfolio and therefore, are extremely relevant to Regulatory Affairs professionals working in a global environment.”

TOPRA’s first North America Symposium was conducted in 2006 with great success and attracted attendees from international organizations in Europe and the United States. TOPRA is the global organization for Regulatory Affairs professionals and for those who have an interest in Regulatory Affairs in the healthcare sector. Current membership is drawn from over 40 countries worldwide.

To register or to obtain additional information about the 2nd TOPRA North America Symposium, please visit the TOPRA website.

About TOPRA

TOPRA is a non-profit, non-political organization, which seeks to advance the status of the regulatory profession through education, and provision of information to its members.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


TOPRA Announces 2nd Annual North America Symposium

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Monique Garrett 
610 535 6500 mgarrett[.]octagonresearch.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com

Visit  RightITnow Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today